Your position:www.healthoo.com >> EN >> EN >> Formulation >> Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma >> article
 
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma
Editor:xuezhe     Clicks:0    Date:2023-3-31 15:49:12
Keyword: Received orphan drug
Healthoo Information:
Received orphan drug recognition! Shanghai Pharmaceutical SPH4336 breakthrough liposarcoma
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • THE BULK DRUG PARKS SCHEME
  • 2022 global new drug inventory: "First-in-class" therapy accounted for...
  • Domestic anti-HIV new drug, Addison Pharmaceuticals "Inomitine Tablets...
  • Inventory in 2022: Overview of "Five Xiaoqiang" Export of Veterinary D...
  • The battle between Pfizer Gilead over COVID-19 drugs will continue
  • When is "water inverse" going on? Biogens ALS drug approval delayed to...
  • Market Report of Monoclonal Antibody Drugs in China (2022)
  • The Veterinary Drug Industry is Facing a Period of Opportunity for Cha...
  • Innovative drugs - Medium long-term growth still has more room for imp...
  • Chinas innovative drugs entering the global market is the future trend...
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463